Read the Results from Clinical Studies published by Nature Portfolio NPJ | Digital Medicine, Introducing the Next-Generation Wearable Technology
Cambridge, Massachusetts--(Newsfile Corp. - March 21, 2023) - MindMics, Inc. reported results from the clinical studies of revolutionary earbuds that use a new technology - In-ear Infrasonic Hemodynography with a digital health device for cardiovascular monitoring using the human audiome. These results were published by Nature Portfolio NPJ | Digital Medicine: https://www.nature.com/articles/s41746-022-00725-3.
Human bodily mechanisms and functions produce low-frequency sounds. Our range of hearing limits our ability to perceive these sounds. However, In-ear Infrasonic Hemodynography (IH), invented and patented by MindMics, provides a path to enable health monitoring using microphones often already embedded in TWS earbuds for Active Noise Cancelation (ANC). The sound-based nature of this biometric monitoring capability overcomes issues related to first-generation light-based PPG technology used in wearables today, such as skin tone, limited accuracy, and the need for battery-draining optical sensors.
